Flow cytometric detection of minimal residual disease in B-lineage acute lymphoblastic leukemia by using "MRD lite" panel.

about

Flow cytometric detection of minimal residual disease in B-lineage acute lymphoblastic leukemia by using "MRD lite" panel.

Item

http://www.wikidata.org/entity/Q53717785

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Flow cytometric detection of m ...... mia by using "MRD lite" panel.

@en

Flow cytometric detection of m ...... mia by using "MRD lite" panel.

@nl

type

Item

label

Flow cytometric detection of m ...... mia by using "MRD lite" panel.

@en

Flow cytometric detection of m ...... mia by using "MRD lite" panel.

@nl

prefLabel

Flow cytometric detection of m ...... mia by using "MRD lite" panel.

@en

Flow cytometric detection of m ...... mia by using "MRD lite" panel.

@nl

P1476

Flow cytometric detection of m ...... mia by using "MRD lite" panel.

@en

P2093

Tathagata Chatterjee

http://www.w3.org/2001/XMLSchema#string

Venkatesan Somasundaram

http://www.w3.org/2001/XMLSchema#string

P2860

Minimal residual disease diagnostics in acute lymphoblastic leukemia: need for sensitive, fast, and standardized technologies

Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data.

Assessing minimal residual disease (MRD) in leukemia: a changing definition and concept?

Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG).

A simplified flow cytometric assay identifies children with acute lymphoblastic leukemia who have a superior clinical outcome.

Prognostic significance of monitoring leukemia-associated immunophenotypes by eight-color flow cytometry in adult B-acute lymphoblastic leukemia

Standardized MRD quantification in European ALL trials: proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008.

Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study.

Standardization of flow cytometric minimal residual disease evaluation in acute lymphoblastic leukemia: Multicentric assessment is feasible.

Methodological aspects of minimal residual disease assessment by flow cytometry in acute lymphoblastic leukemia: A French multicenter study.

P304

54-57

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.MJAFI.2016.10.006

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-12-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28123246

http://www.w3.org/2001/XMLSchema#string

P932

5221346

http://www.w3.org/2001/XMLSchema#string